1. Medtech Insight
  2. >>Policy & Regulation

Four Republican Senators Say They Oppose Obamacare Replacement Plan

 
• By Sue Darcey

In a March 6 letter to Sen. Majority Leader Mitch McConnell, R-Kent., four GOP senators said they oppose a Feb. 10 Obamacare "Repeal and Replace" plan that has been circulating around Congress because it does not provide stability or certainty for individuals in Medicaid expansion programs. A device tax repeal is included in the plan.

Four Republican senators sent a letter to Senate Majority Leader Mitch McConnell March 6 saying they do not support a recent Affordable Care Act "repeal and replacement" plan that is being circulated in the US Congress due to concerns about funding and coverage for Medicaid expansion. A copy of the letter to McConnell is available on Sen. Cory Gardner's, R-Colo., website.

Gardner, Rob Portman, R-Ohio, Shelley Moore Capito, R-W.Va., and Lisa Murkowski, R-Alaska, told McConnell in the letter that a Feb....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Brazil’s Medtechs Look To Solutions After 50% US Tariff Hit Amid ‘Scenario Of Uncertainty’

 
• By Bernard Murphy

Hopes that last-minute negotiations might exempt Brazil’s $300m medtech exports from the latest round of US tariffs have been dashed, leaving the industry braced for further market instability that countermeasures could trigger.

Survey Reveals Gaps In Medtech Compliance Processes

 
• By Elizabeth Orr

Medical device firms often have serious compliance gaps, a recent Veeva MedTech survey found. Only 50% of the companies surveyed are confident in their global registration data, with 70% reporting inconsistencies during audits. The report recommends automation and better data governance.

Environmental Group Questions FDA’s Stance On PFAS In Medical Devices

 
• By Brian Bossetta

The US FDA says PFAS used in medical devices are safe and that there’s no reason to restrict them in device production. An environmental group finds the agency’s assertion questionable.